MGIM
VIVO

M&G Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

M&G Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-194,284
Closed -$3.69K – 785
2021
Q3 		$3.69K Buy
194,284
+228
+0.1% +$4.54K 0.01% 451
2021
Q2 		$4.27K Sell
194,056
-67,631
-26% -$1.43M 0.01% 425
2021
Q1 		$6.8K Buy
261,687
+201,024
+331% +$4.78M 0.02% 210
2020
Q4 		$1.15K Buy
+60,663
New +$1.13M 0.01% 306
2020
Q1 		– Sell
-224,034
Closed -$2.24M – 455
2019
Q4 		$2.24M Buy
+224,034
New +$2.1M 0.02% 265

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

M&G Investment Management's VIVO Position: Q4 2021 in Review

M&G Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q4 2021, closing a stake of 194,284 shares — an estimated $3.69K sold.

M&G Investment Management first reported a position in VIVO in Q4 2019 and held it in 5 quarters. The position peaked at $2.24M in Q4 2019. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2021.

  • M&G Investment Management reported no remaining Meridian Bioscience Inc position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 194,284 Meridian Bioscience Inc shares in Q4 2021, an estimated $3.69K.
  • M&G Investment Management first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 5 quarters.
  • M&G Investment Management's Meridian Bioscience Inc position peaked at $2.24M in Q4 2019.
  • 180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.